Free Trial
TSE:MDP

Medexus Pharmaceuticals (MDP) Stock Price, News & Analysis

Medexus Pharmaceuticals logo
C$2.87 +0.05 (+1.77%)
As of 11:31 AM Eastern

About Medexus Pharmaceuticals Stock (TSE:MDP)

Key Stats

Today's Range
C$2.85
C$2.90
50-Day Range
C$2.50
C$3.40
52-Week Range
C$1.71
C$5.56
Volume
5,902 shs
Average Volume
77,468 shs
Market Capitalization
C$64.25 million
P/E Ratio
13.72
Dividend Yield
N/A
Price Target
C$5.49
Consensus Rating
Buy

Company Overview

Medexus Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

MDP MarketRank™: 

Medexus Pharmaceuticals scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medexus Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.29, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medexus Pharmaceuticals has received no research coverage in the past 90 days.

  • Read more about Medexus Pharmaceuticals' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medexus Pharmaceuticals is 13.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medexus Pharmaceuticals is 13.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.18.

  • Price to Book Value per Share Ratio

    Medexus Pharmaceuticals has a P/B Ratio of 2.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for MDP.
  • Dividend Yield

    Medexus Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Medexus Pharmaceuticals does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MDP.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Medexus Pharmaceuticals this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Medexus Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.14% of the stock of Medexus Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 8.32% of the stock of Medexus Pharmaceuticals is held by institutions.

  • Read more about Medexus Pharmaceuticals' insider trading history.
Receive MDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MDP Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

MDP Stock Analysis - Frequently Asked Questions

Medexus Pharmaceuticals' stock was trading at C$3.46 on January 1st, 2025. Since then, MDP stock has decreased by 18.5% and is now trading at C$2.82.

Shares of MDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medexus Pharmaceuticals investors own include AutoZone (AZO), Cisco Systems (CSCO), Facedrive (FDVRF), Intel (INTC), kneat.com (KSI), NIO (NIO) and Nanotech Security (NTS).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:MDP
CIK
N/A
Fax
N/A
Employees
98
Year Founded
N/A

Price Target and Rating

High Price Target
C$8.25
Low Price Target
C$3.45
Potential Upside/Downside
+94.6%
Consensus Rating
Buy
Rating Score (0-4)
3.29
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
C$0.21
Trailing P/E Ratio
13.49
Forward P/E Ratio
17.27
P/E Growth
N/A
Net Income
C$3.26 million
Net Margins
3.25%
Pretax Margin
N/A
Return on Equity
11.07%
Return on Assets
4.89%

Debt

Debt-to-Equity Ratio
120.58
Current Ratio
1.01
Quick Ratio
N/A

Sales & Book Value

Annual Sales
C$100.25 million
Price / Sales
0.63
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
C$1.35 per share
Price / Book
2.08

Miscellaneous

Outstanding Shares
22,388,156
Free Float
N/A
Market Cap
C$63.13 million
Optionable
Not Optionable
Beta
1.96
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (TSE:MDP) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners